Douglass Winthrop Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,014	Closed	-$340K	–	260
2022 Q1	$340K	Hold	14,014	–	–	0.01%	223
2021 Q4	$451K	Hold	14,014	–	–	0.01%	205
2021 Q3	$626K	Hold	14,014	–	–	0.02%	173
2021 Q2	$530K	Buy	+14,014	New	+$530K	0.01%	190